Discovery offers hope for new schizophrenia drugs

Australian researchers have found that a subgroup of patients have raised kynurenic acid in the brain

A discovery that a subgroup of patients with schizophrenia have increased production of kynurenic acid in the brain could pave the way for new drug treatment targets, Australian researchers say.